Review
Copyright ©The Author(s) 2020.
World J Clin Cases. Sep 6, 2020; 8(17): 3621-3644
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3621
Figure 1
Figure 1 Immunologic pathways activated by severe acute respiratory syndrome coronavirus 2. SARS-CoV2: Severe acute respiratory syndrome coronavirus 2; TLR: Toll-like receptor; IL: Interleukin; NLRP3: Nucleotide oligomerization domain-like receptor family pyrin domain (PYD)-containing 3; NF-kB: Nuclear factor-kB; RIG-I: Retinoic-acid inducible gene I; MDA5: Melanoma differentiation-associated protein 5; IFN-I: Type I interferon; pDC: Plasmacytoid dendritic cell; MHC: Major histocompatibility complex; TCR: T cell receptor; Th: T helper; NET: Neutrophil extracellular trap.
Figure 2
Figure 2 Organ localization of immune-mediated disorders related to severe acute respiratory syndrome coronavirus 2 infection.